Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

NCT00280215 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00280215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2007
Completion date
December 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperoxaluria